8364 related articles for article (PubMed ID: 2298142)
1. [Modifying effects of recombinant tumor necrosis factor on the metastatic potential of tumor cells].
Kudriavets IuI
Eksp Onkol; 1990; 12(1):43-7. PubMed ID: 2298142
[TBL] [Abstract][Full Text] [Related]
2. [Recombinant tumor necrosis factor promotes the formation of hematogenic metastases to the lungs of C57Bl/6 mice].
Kudriavets IuI; Didkovskaia LP
Eksp Onkol; 1990; 12(2):47-50. PubMed ID: 2318134
[TBL] [Abstract][Full Text] [Related]
3. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
[TBL] [Abstract][Full Text] [Related]
4. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
[TBL] [Abstract][Full Text] [Related]
6. [Recombinant tumor necrosis factor modifies the metastatic potential of tumor cells].
Kudriavets IuI
Dokl Akad Nauk SSSR; 1989; 309(6):1486-91. PubMed ID: 2632213
[No Abstract] [Full Text] [Related]
7. Role of tissue factor in the antitumor effect of recombinant human tumor necrosis factor-alpha in mice.
Nishigaki F; Miyayasu K; Tsujimoto S; Manda T; Shimomura K
Anticancer Res; 1994; 14(6B):2573-6. PubMed ID: 7872683
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
Tomazic VJ; Farha M; Loftus A; Elias EG
J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
[TBL] [Abstract][Full Text] [Related]
9. Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis.
Okahara H; Yagita H; Miyake K; Okumura K
Cancer Res; 1994 Jun; 54(12):3233-6. PubMed ID: 7515767
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of metastatic potential of mouse B16-melanoma cells to lung after treatment with gangliosides of B-16-melanoma cells of higher metastatic potential to lung.
Saha S; Mohanty KC
Indian J Exp Biol; 2003 Nov; 41(11):1253-8. PubMed ID: 15332492
[TBL] [Abstract][Full Text] [Related]
11. Secretion of metastasis related gangliosides by mouse B16-melanoma in circulation in vivo and in culture media in vitro.
Saha S; Mohanty KC
Indian J Exp Biol; 2004 Oct; 42(10):976-80. PubMed ID: 15511000
[TBL] [Abstract][Full Text] [Related]
12. Prolonged survival of tumor-bearing rats with repetitive low-dose recombinant tumor necrosis factor.
Sheppard BC; Venzon D; Fraker DL; Langstein HN; Jensen JC; Norton JA
Cancer Res; 1990 Jul; 50(13):3928-33. PubMed ID: 2354441
[TBL] [Abstract][Full Text] [Related]
13. Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells.
Khatib AM; Kontogiannea M; Fallavollita L; Jamison B; Meterissian S; Brodt P
Cancer Res; 1999 Mar; 59(6):1356-61. PubMed ID: 10096570
[TBL] [Abstract][Full Text] [Related]
14. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
15. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors.
Talmadge JE; Fidler IJ
J Natl Cancer Inst; 1982 Oct; 69(4):975-80. PubMed ID: 6750200
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of the toxicity of tumor necrosis factor by tumors in mice.
Nishigaki F; Miyayasu K; Tsujimoto S; Manda T; Shimomura K
Circ Shock; 1994 Oct; 44(2):77-83. PubMed ID: 7743604
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition of tumor invasion and metastasis by retinoid 4-APR].
Shi B; Li LM; You SQ; Xu SP; Han R
Yao Xue Xue Bao; 1997; 32(1):33-7. PubMed ID: 11243215
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model.
Kobayashi H; Gotoh J; Shinohara H; Moniwa N; Terao T
Thromb Haemost; 1994 Apr; 71(4):474-80. PubMed ID: 8052966
[TBL] [Abstract][Full Text] [Related]
19. Loss of the H-2.33 private specificity by 3LL tumor cells correlates with the tumor potential to metastasize across the H-2K region genetic barriers.
Isakov N; Feldman M; Segal S
Exp Clin Immunogenet; 1984; 1(3):170-4. PubMed ID: 6401004
[TBL] [Abstract][Full Text] [Related]
20. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals.
Hidvégi M; Ráso E; Tömösközi-Farkas R; Paku S; Lapis K; Szende B
Anticancer Res; 1998; 18(4A):2353-8. PubMed ID: 9703878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
